17-Phenoxy trinor prostaglandin F2α ethyl amide  (Synonyms: 17-Phenoxy trinor PGF2α ethyl amide)

17-Phenoxy trinor prostaglandin F2α ethyl amide (17-Phenoxy trinor PGF2α ethyl amide) is an analog of Bimatoprost (HY-12956). 17-Phenoxy trinor prostaglandin F2α ethyl amide is an agonist for Prostaglandin F2α Receptor (FP receptor). 17-Phenoxy trinor prostaglandin F2α ethyl amide is potent to reduce the intraocular pressure and attenuate the glaucoma^[1][2].

431.56

C₂₅H₃₇NO₅

1421369-12-1

O[C@@H]1[C@@H]([C@H]([C@@H](C1)O)/C=C/[C@H](CCOC2=CC=CC=C2)O)C/C=C\CCCC(N(CC)[H])=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Balapure AK, et al., Structural requirements for prostaglandin analog interaction with the ovine corpus luteum prostaglandin F2 alpha receptor. Implications for development of a photoaffinity probe. Biochem Pharmacol. 1989 Jul 15;38(14):2375-81.  [Content Brief]

  [2]. Woodward DF, et al., Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). J Pharmacol Exp Ther. 2003 May;305(2):772-85.  [Content Brief]